健康绝经后女性血清促卵泡激素与5年肥胖度变化
在667名健康绝经后女性中,横断面分析显示FSH与各项肥胖指标呈负相关,调整E2后关联不变;纵向分析中,停用激素治疗的242名女性FSH升高最多(+33.9 mIU/mL)、E2下降最多(-44.3 pg/mL),FSH升高与全身脂肪百分比、全身脂肪质量和皮下脂肪组织增加相关。
要点
- 横断面分析中,FSH与所有肥胖指标呈负相关,调整E2后关联不变。
- 纵向分析中,停用激素治疗者FSH升高最多(+33.9 mIU/mL)、E2下降最多(-44.3 pg/mL)。
- 调整后,FSH升高与全身脂肪百分比、全身脂肪质量和皮下脂肪组织增加相关。
核心结论
- 横断面分析提示FSH与肥胖度呈负相关,而纵向分析提示FSH升高幅度越大,全身脂肪百分比、全身脂肪质量和皮下脂肪组织的增加幅度越大。
- 作者指出未来需要在更大样本中进一步研究FSH与肥胖度的机制。
研究设计与样本
- 研究样本为来自妇女健康倡议布法罗骨牙周辅助研究的667名绝经后女性。
- 采用横断面和纵向分析(5年随访),评估血清FSH和E2水平与双能X线吸收法(DXA)测定的肥胖指标之间的关联,并考虑雌二醇和绝经后激素治疗使用情况。
主要发现
- 横断面分析中,在调整年龄、绝经年数、吸烟状态、包-年和激素治疗使用的模型中,FSH水平与所有肥胖指标呈负相关;这些关联不受血清E2调整的影响。
- 纵向分析中,随访期间停用激素治疗的亚组(n=242)在未调整分析中FSH升高最多(+33.9 mIU/mL)、E2下降最多(-44.3 pg/mL),且所有肥胖指标增加。
- 调整分析中,FSH升高与全身脂肪百分比、全身脂肪质量和皮下脂肪组织(SAT)的增加相关。
局限性
- 作者指出未来需要在更大样本中进一步研究,以提供关于FSH与肥胖度机制的更多见解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Evidence from animal studies suggests that the gradual rise in follicle-stimulating hormone (FSH) during reproductive senescence may contribute to the change in adiposity distribution characteristic of menopause. The potential independent role the interrelationships of FSH and estradiol (E2) may play in postmenopausal adiposity changes are not well studied. OBJECTIVE: Our objective was to evaluate the associations of FSH and dual x-ray absorptiometry (DXA)-derived adiposity measures, with consideration of estradiol and postmenopausal hormone therapy use. METHODS: In a sample of 667 postmenopausal women from the Women's Health Initiative Buffalo OsteoPerio Ancillary Study, we studied the associations of serum FSH and E2 levels with dual x-ray absorptiometry (DXA)-derived adiposity measures via cross-sectional and longitudinal analyses (5-year follow-up). RESULTS: In cross-sectional analyses, FSH levels were inversely associated with all measures of adiposity in models adjusted for age, years since menopause, smoking status, pack-years, and hormone therapy (HT) use; these associations were not influenced by adjustment for serum E2. In longitudinal analyses, the subset of women who discontinued HT over follow-up (n = 242) experienced the largest increase in FSH (+33.9 mIU/mL) and decrease in E2 (-44.3 pg/mL) and gains in all adiposity measures in unadjusted analyses. In adjusted analyses, an increase in FSH was associated with a gain in percentage of total body fat, total body fat mass, and subcutaneous adipose tissue (SAT). CONCLUSION: While cross-sectional findings suggest that FSH is inversely associated with adiposity, our longitudinal findings suggest that greater increases in FSH were associated with greater increases in percentage of total body fat, total body fat mass, and SAT. Future studies are needed to provide additional insight into FSH-adiposity mechanisms in larger samples.
引用
- Mattick LJ, Bea JW, Singh L, et al. Serum Follicle-Stimulating Hormone and 5-Year Change in Adiposity in Healthy Postmenopausal Women. J Clin Endocrinol Metab. 2022. PMID: 35435955. doi:10.1210/clinem/dgac238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。